+

WO2002000851A3 - Helicobacter dd-heptosyltransferase - Google Patents

Helicobacter dd-heptosyltransferase Download PDF

Info

Publication number
WO2002000851A3
WO2002000851A3 PCT/CA2001/000969 CA0100969W WO0200851A3 WO 2002000851 A3 WO2002000851 A3 WO 2002000851A3 CA 0100969 W CA0100969 W CA 0100969W WO 0200851 A3 WO0200851 A3 WO 0200851A3
Authority
WO
WIPO (PCT)
Prior art keywords
heptosyltransferase
helicobacter
polypeptides
relates
polynucleotides
Prior art date
Application number
PCT/CA2001/000969
Other languages
English (en)
Other versions
WO2002000851A2 (fr
Inventor
Koji Hiratsuka
Eleonora Altman
Original Assignee
Ca Nat Research Council
Koji Hiratsuka
Eleonora Altman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CA2000/000777 external-priority patent/WO2001000796A2/fr
Application filed by Ca Nat Research Council, Koji Hiratsuka, Eleonora Altman filed Critical Ca Nat Research Council
Priority to EP01947090A priority Critical patent/EP1299527A2/fr
Priority to AU2001268885A priority patent/AU2001268885A1/en
Priority to US10/451,685 priority patent/US20040110261A1/en
Priority to CA002417692A priority patent/CA2417692A1/fr
Publication of WO2002000851A2 publication Critical patent/WO2002000851A2/fr
Publication of WO2002000851A3 publication Critical patent/WO2002000851A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1081—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Cette invention se rapporte à des polynucléotides et polypeptides nouvellement identifiés, et à leur production et à leurs utilisations, ainsi qu'à leurs variants, agonistes et antagonistes, et à leurs utilisations. Cette invention concerne en particulier de nouveaux polynucléotides et polypeptides d'heptosyltransférase.
PCT/CA2001/000969 2000-06-28 2001-06-28 Helicobacter dd-heptosyltransferase WO2002000851A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP01947090A EP1299527A2 (fr) 2000-06-28 2001-06-28 Helicobacter dd-heptosyltransferase
AU2001268885A AU2001268885A1 (en) 2000-06-28 2001-06-28 Helicobacter dd-heptosyltransferase
US10/451,685 US20040110261A1 (en) 2000-06-28 2001-06-28 Helicobacter dd-heptosyltransferase
CA002417692A CA2417692A1 (fr) 2000-06-28 2001-06-28 Helicobacter dd-heptosyltransferase

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/CA2000/000777 WO2001000796A2 (fr) 1999-06-28 2000-06-28 Glycosyltransferases de helicobacter pylori utilisees comme nouvelle cible dans la prevention et le traitement des infections par h. pylori
CAPCT/CA00/00777 2000-06-28
US25757400P 2000-12-21 2000-12-21
US60/257,574 2000-12-21

Publications (2)

Publication Number Publication Date
WO2002000851A2 WO2002000851A2 (fr) 2002-01-03
WO2002000851A3 true WO2002000851A3 (fr) 2002-03-28

Family

ID=25673729

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2001/000969 WO2002000851A2 (fr) 2000-06-28 2001-06-28 Helicobacter dd-heptosyltransferase

Country Status (3)

Country Link
EP (1) EP1299527A2 (fr)
AU (1) AU2001268885A1 (fr)
WO (1) WO2002000851A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1886685A1 (fr) 2006-08-11 2008-02-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Méthodes, utilisations et compositions pour la modulation de la réplication du HCV par activation ou inhibition du récepteur farnesoid X
SG182589A1 (en) 2010-01-29 2012-08-30 Vertex Pharma Therapies for treating hepatitis c virus infection
WO2012107589A1 (fr) 2011-02-11 2012-08-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Méthodes et compositions pharmaceutiques pour le traitement et la prévention des infections à vhc
CN109312379B (zh) 2016-04-05 2022-04-12 科学与工业研究委员会 多功能重组核苷酸依赖性糖基转移酶蛋白及其糖基化的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040893A1 (fr) * 1995-06-07 1996-12-19 Astra Aktiebolag Sequences d'acide nucleique et d'acides amines concernant helicobacter pylori, utilisees a des fins diagnostiques et therapeutiques
WO2001000796A2 (fr) * 1999-06-28 2001-01-04 National Research Council Of Canada Glycosyltransferases de helicobacter pylori utilisees comme nouvelle cible dans la prevention et le traitement des infections par h. pylori

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040893A1 (fr) * 1995-06-07 1996-12-19 Astra Aktiebolag Sequences d'acide nucleique et d'acides amines concernant helicobacter pylori, utilisees a des fins diagnostiques et therapeutiques
WO2001000796A2 (fr) * 1999-06-28 2001-01-04 National Research Council Of Canada Glycosyltransferases de helicobacter pylori utilisees comme nouvelle cible dans la prevention et le traitement des infections par h. pylori

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ALM RICHARD A ET AL: "Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori.", NATURE (LONDON), vol. 397, no. 6715, 14 January 1999 (1999-01-14), pages 176 - 180, XP002183092, ISSN: 0028-0836 *
DATABASE EMBL 18 January 1999 (1999-01-18), ALM R A ET AL: "Helicobacter pylori, strain J99 section 38 of 132 of the complete genome", XP002183095 *
DATABASE EMBL 25 August 1997 (1997-08-25), TOMB J -F ET AL: "Helicobacter pylori 26695 section 24 of 134 of the complete genome", XP002183094 *
DATABASE EMBL 25 August 1997 (1997-08-25), TOMB J -F ET AL: "Helicobacter pylori 26695 section 40 of 134 of the complete genome.", XP002183099 *
H. PYLORI GENES THAT HAVE A HOMOLOG TO NEITHER E. COLI NOR H. INFLUENZAE, 18 August 1997 (1997-08-18), XP002183091, Retrieved from the Internet <URL:http://www.bork.embl-heidelberg.de/Genome/HitsHPnonHIEC.shtml> [retrieved on 20011115] *
MONTEIRO MARIO A ET AL: "Lipopolysaccharide structures of Helicobacter pylori genomic strains 26695 and J99, mouse model H. pylori Sydney strain, H. pylori P466 carrying sialyl Lewis X, and H. pylori UA915 expressing Lewis B. Classification of H. pylori lipopolysaccharides into glycotypes families.", EUROPEAN JOURNAL OF BIOCHEMISTRY, vol. 267, no. 2, January 2000 (2000-01-01), pages 305 - 320, XP002183093, ISSN: 0014-2956 *
TOMB J -F ET AL: "THE COMPLETE GENOME SEQUENCE OF THE GASTRIC PATHOGEN HELICOBACTER PYLORI", NATURE,GB,MACMILLAN JOURNALS LTD. LONDON, vol. 388, no. 6642, 7 August 1997 (1997-08-07), pages 539 - 547,TABEL, XP002062106, ISSN: 0028-0836 *

Also Published As

Publication number Publication date
WO2002000851A2 (fr) 2002-01-03
AU2001268885A1 (en) 2002-01-08
EP1299527A2 (fr) 2003-04-09

Similar Documents

Publication Publication Date Title
NL300390I1 (en) Anti-IL-12 antibodies, compositions, methods and uses.
ZA200407666B (en) Pyridinoylpiperidines as 5-HTif agonists.
ZA200405560B (en) Screw cap composition.
EP1617802A4 (fr) Polynucleotides specifiques de cngh0010, polypeptides, anticorps, compositions, methodes et utilisations
WO2004029087A3 (fr) Recepteurs du gout amer
ZA200208489B (en) Salt-sensitive, water-dispersible polymer composition.
ZA200207568B (en) Card for multi-purpose using.
WO2004112703A3 (fr) Analogues de l&#39;interleukine-21
MXPA03001863A (es) Composicion de poliamida para la formacion de fibra.
WO2001002571A3 (fr) Nouvel antagoniste du recepteur d&#39;interleukin-1 et ses utilisations
WO2005087793A3 (fr) Compositions immunostimulatrices et leurs utilisations
WO2001075068A3 (fr) Proteines secretee et polynucleotides codant pour ces proteines
WO2002002630A3 (fr) Nouvelles utilisations
ZA200105737B (en) N-Triazolyl-methyl-piperazine derivates as neurokinin- receptor antagonists.
EG23439A (en) Olefins production process.
EG23378A (en) Composition.
WO2005076696A3 (fr) Derives de pneumolysine
ZA200500888B (en) Novel albumins.
WO2002000851A3 (fr) Helicobacter dd-heptosyltransferase
HK1054413A1 (en) Vertical shingle connecting structure.
EP1599598A4 (fr) Polypeptides pon, polynucleotides les codant et compositions et procedes utilisant ces derniers
ZA200103695B (en) Process for the manufacture in pure form of 1-pentene or alpha-olefin lower than 1-pentene.
MXPA03001504A (es) Seecion de linea de produccion.
MXPA01012693A (es) Produccion mejorada de tequila.
WO2006063028A3 (fr) Compositions immunostimulantes et utilisations de celles-ci

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2001947090

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2417692

Country of ref document: CA

WWP Wipo information: published in national office

Ref document number: 2001947090

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 10451685

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001947090

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载